Literature DB >> 16624837

PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients.

Steina Aradottir1, Gulber Asanovska, Stefan Gjerss, Per Hansson, Christer Alling.   

Abstract

AIMS: Phosphatidylethanol (PEth) is an abnormal phospholipid formed only in the presence of ethanol by the enzyme phospholipase D. PEth in blood is a promising new marker for ethanol abuse. None of the biological markers used at the present time is sensitive and specific enough for the diagnosis of alcoholism.
METHODS: The most frequently used alcohol markers [carbohydrate deficient transferrin (CDT), gamma-glutamyltransferase (GGT), and mean corpuscular volume (MCV)] were studied together with PEth in actively drinking alcohol-dependent patients (inpatients and outpatients), with regard to correlation to ethanol intake and diagnostic sensitivity of the markers. The relation between the markers was also studied.
RESULTS: PEth, CDT, and GGT correlated to ethanol intake, with the strongest correlation found for PEth. The diagnostic sensitivity for PEth was 99%, and for other markers it varied between 40 and 77%. Only when CDT was combined with GGT was a sensitivity of 94% reached. PEth correlated to CDT and GGT but not to MCV. CDT did not correlate to GGT or MCV.
CONCLUSIONS: Blood concentrations of PEth are highly correlated to ethanol intake, and the present results indicate that its diagnostic sensitivity is higher than that for previously established alcohol markers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624837     DOI: 10.1093/alcalc/agl027

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  70 in total

1.  Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients.

Authors:  Scott H Stewart; David G Koch; Douglas M Burgess; Ira R Willner; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2012-06-22       Impact factor: 3.455

2.  An integrated videoconferencing intervention for chronic pain and heavy drinking among patients in HIV-care: a proof-of-concept study.

Authors:  Tibor P Palfai; Richard Saitz; Maya P L Kratzer; Jessica L Taylor; John D Otis; Judith A Bernstein
Journal:  AIDS Care       Date:  2020-06-11

3.  Levels and types of alcohol biomarkers in DUI and clinic samples for estimating workplace alcohol problems.

Authors:  Paul R Marques
Journal:  Drug Test Anal       Date:  2012-02-06       Impact factor: 3.345

4.  Binge Alcohol Is More Injurious to Liver in Female than in Male Rats: Histopathological, Pharmacologic, and Epigenetic Profiles.

Authors:  Shivendra D Shukla; Ricardo Restrepo; Annayya R Aroor; Xuanyou Liu; Robert W Lim; Jacob D Franke; David A Ford; Ronald J Korthuis
Journal:  J Pharmacol Exp Ther       Date:  2019-07-01       Impact factor: 4.030

5.  Phosphatidylethanol in Comparison to Self-Reported Alcohol Consumption Among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking.

Authors:  Yan Wang; Xinguang Chen; Judith A Hahn; Babette Brumback; Zhi Zhou; Maria J Miguez; Robert L Cook
Journal:  Alcohol Clin Exp Res       Date:  2017-12-05       Impact factor: 3.455

Review 6.  [What ethanol metabolites as biological markers tell us about alcohol use].

Authors:  Friedrich Martin Wurst; Natasha Thon; Wolfgang Weinmann; Michel Yegles; Ulrich Preuss
Journal:  Wien Med Wochenschr       Date:  2013-12-10

7.  Declining and rebounding unhealthy alcohol consumption during the first year of HIV care in rural Uganda, using phosphatidylethanol to augment self-report.

Authors:  Judith A Hahn; Nneka I Emenyonu; Robin Fatch; Winnie R Muyindike; Allen Kekiibina; Adam W Carrico; Sarah Woolf-King; Stephen Shiboski
Journal:  Addiction       Date:  2015-11-05       Impact factor: 6.526

8.  Reduction in Drinking was Associated With Improved Clinical Outcomes in Women With HIV Infection and Unhealthy Alcohol Use: Results From a Randomized Clinical Trial of Oral Naltrexone Versus Placebo.

Authors:  Robert L Cook; Zhi Zhou; Maria Jose Miguez; Clery Quiros; Luis Espinoza; John E Lewis; Babette Brumback; Kendall Bryant
Journal:  Alcohol Clin Exp Res       Date:  2019-07-10       Impact factor: 3.455

9.  Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users.

Authors:  Jennifer Jain; Jennifer L Evans; Alya Briceño; Kimberly Page; Judith A Hahn
Journal:  Alcohol Alcohol       Date:  2014-06-17       Impact factor: 2.826

10.  The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.

Authors:  Ludmila N Bakhireva; Renate D Savich; Dennis W Raisch; Sandra Cano; Robert D Annett; Lawrence Leeman; Mahek Garg; Chelsea Goff; Daniel D Savage
Journal:  Alcohol Clin Exp Res       Date:  2013-02-19       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.